Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s revision indicator updated from Revision: v3.6.2 to Revision: v3.6.3, signaling a software version update to the study details page.SummaryDifference0.1%

- Check17 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, signaling a small behind-the-scenes update to the page's documentation or formatting.SummaryDifference0.1%

- Check31 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. A revision note shows the page version updated to v3.6.0.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a minor backend or template update rather than changes to the study data or content visible on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3; this indicates a deployment-level update rather than a change to study information.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page’s footer revision identifier was updated from **v3.5.2** to **v3.5.3**, indicating a minor site/version release without changing the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.